CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price ...Middle East

HOUSTON, Nov. 30, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing...

Hence then, the article about cns pharmaceuticals announces pricing of 6 0 million public offering at a premium to the market closing price was published today ( Thursday 01/12/2022 - 06:24 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price )

Also on site :

• Five killed in helicopter crash on Africa’s highest mountain (VIDEO)
• Presidency’s General Secretariat reviews Social Insurance institution performance
• The Christmas Day Storm